Industry Leads for the Week of July 29, 2019
Kentucky Log Still Distilling, LLC is planning to establish a bourbon distillery at the 220-acre former Gethsemane Distillery site in New Haven. The project scope includes renovation and construction of building space for distilling, bottling and barrel warehouses; and purchase and installation of stainless-steel piping, fermentation tanks, and distilling, blending, filling, flow-control, packaging and stillage-processing equipment. Doss and Horky Inc. has been selected as the prime contractor for the project. Construction is expected to begin in December 2019. Log Still Distilling will use the facility to produce bourbon, rye whiskey, gin and vodka. The estimated EPC cost is $12 million. Log Still Distilling, LLC, 3010 Old Hillsboro Rd., Franklin, Tenn., 37604. IR#KY190610.
Texas MarkWest Energy Partners, L.P. is considering constructing a natural gas liquids fractionator in Brazoria County. The project scope includes construction of equipment foundations; purchase and erection of structural steel; fabrication and erection of NGL storage tanks; and purchase and installation of fractionation towers, heat exchangers, and supporting equipment and systems. Construction is expected to begin in the fourth quarter of 2020, pending corporate approvals. MarkWest Energy Partners is a subsidiary of MPLX LP, based in Findlay, Ohio. The estimated EPC cost is $460 million. MarkWest Energy Partners, L.P., 2448 East 81st St., Tulsa, Okla., 74137. IR#TX190627.
Washington Selkirk Pharma is planning to construct a pharmaceutical manufacturing facility at the Pacific Northwest Technology Park in Spokane. The project scope includes construction of a 65,000-sq-ft building with cleanrooms and sterile formulation and fill suites; and purchase and installation of wet laboratory and packaging equipment and systems. Bernardo-Wills Architects and BCA Architects have been selected to provide design services for the building. Coffman Engineers has been selected to provide engineering services for the project. Construction is expected to begin late in the third quarter of 2019. Selkirk Pharma will use the facility to provide contract sterile filling and packaging services for the pharmaceutical industry. The estimated EPC cost is $30 million. Selkirk Pharma, 827 West First Ave., Spokane, 99201. IR#WA190605.
Information is derived from Industrial Reports, a market intelligence firm specializing in industrial construction. To receive the full report with details and contacts for any of the above projects, call 800-235-2330 x2002 or email ENRprojects@industrialreports.com. To see all recent projects or to receive new project alerts, go to: http://www.industrialreports.com/enr.
Looking for quick answers on construction and engineering topics?
Try Ask ENR, our new smart AI search tool.
Ask ENR →
